Anne-Sophie Michallet

8PUBLICATIONS
16CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 26, 2024
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Waldenström Macroglobulinemia.

Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar

|Aug 27, 2024
Impact of the total lesion glycolysis (TLG) in predicting response of follicular lymphoma to rituximab.

Paul Emile Pignot, Haifa Bahri, Stéphanie Malartre

|Aug 07, 2023
Clinical outcome of therapy-related acute myeloid leukemia patients. Real-life experience in a University Hospital and a Cancer Center in France.

Amine Belhabri, Mael Heiblig, Stephane Morisset

|Dec 09, 2022
Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.

Louise Laloi, Natacha Chaumard Billotey, Pierre-Yves Dumas

|Dec 11, 2020
First-line treatment of double-hit and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French study.

Marie-Charlotte Laude, Laure Lebras, Pierre Sesques

|Oct 22, 2017
Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group.

Yann Guillermin, Charles Herbaux, Fabien Subtil

Pageof 2

Frequent Collaborators

2 joint publications

Loic Ysebaert

2 joint publications

Amine Belhabri

1 joint publications

Marie-Charlotte Laude

1 joint publications

Pierre Sesques